Source: International Congress 2016 – Clinical update on bronchiectasis



Rating:

Share or cite this content

Citations should be made in the following way:
Jacinto Hernandez Borge (Badajoz, Spain), Amparo Sanz Cabrera, Jacinto Hernandez Borge, Maria del Carmen Garcia Garcia, Maria Jose Antona Rodriguez, Isabel Asschert Aguero, Pedro Pires Goncalvez, Estefanía Molina Ortiz, Ana Castañar Jover, Francisca Lourdes Marquez Perez. Long term prognosis of non-cystic fibrosis bronchiectasis. Eur Respir J 2016; 48: Suppl. 60, 276

Member's Comments

No comment yet.

Related content which might interest you: Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Retrospective cohort study of adult cystic fibrosis patients colonised with achromobacter Xylosoxidans Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Exacerbations in non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Persistence of candida dubliniensis in the lower airways of cystic fibrosis patients Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 A ten year experience of non-cystic fibrosis bronchiectasis from a single center Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 3 Year: 2014 Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Bacterial colonisation in children with non-cystic fibrosis bronchiectasis: a retrospective longitudinal study Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017 International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 Diagnosis and management of non-cystic fibrosis bronchiectasis in children Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Tuberculosis in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016